Group One Trading’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4K Sell
6,900
-22,300
-76% -$85.9K ﹤0.01% 5882
2025
Q4
$116K Buy
29,200
+28,500
+4,071% +$84.5K ﹤0.01% 4872
2025
Q3
$2.18K Sell
700
-4,100
-85% -$13.6K ﹤0.01% 7871
2025
Q2
$16.1K Sell
4,800
-42,700
-90% -$202K ﹤0.01% 6408
2025
Q1
$201K Sell
47,500
-29,100
-38% -$121K ﹤0.01% 4009
2024
Q4
$182K Buy
76,600
+69,400
+964% +$102K ﹤0.01% 4012
2024
Q3
$9.22K Buy
7,200
+7,000
+3,500% +$9.69K ﹤0.01% 5640
2024
Q2
$306 Sell
200
-9,800
-98% -$15.4K ﹤0.01% 6497
2024
Q1
$16.8K Buy
10,000
+6,200
+163% +$12.4K ﹤0.01% 5554
2023
Q4
$6.61K Sell
3,800
-9,500
-71% -$17.4K ﹤0.01% 6399
2023
Q3
$25.1K Buy
13,300
+10,900
+454% +$18.3K ﹤0.01% 5704
2023
Q2
$3.53K Buy
2,400
+800
+50% +$1.38K ﹤0.01% 6871
2023
Q1
$3.12K Buy
+1,600
New +$3.8K ﹤0.01% 6489
2018
Q3
Sell
-100
Closed -$1K 5240
2018
Q2
$1K Sell
100
-500
-83% -$3.13K ﹤0.01% 4986
2018
Q1
$4K Buy
+600
New +$4.13K ﹤0.01% 4544
2015
Q4
Sell
-6,600
Closed -$38K 4782
2015
Q3
$38K Sell
6,600
-300
-4% -$1.87K ﹤0.01% 3698
2015
Q2
$49K Buy
6,900
+5,600
+431% +$38.9K ﹤0.01% 3542
2015
Q1
$9K Buy
+1,300
New +$8.11K ﹤0.01% 4171
2014
Q3
Sell
-9,200
Closed -$41K 5164
2014
Q2
$41K Hold
9,200
﹤0.01% 3665
2014
Q1
$41K Buy
+9,200
New +$43.8K ﹤0.01% 3759
2013
Q3
Sell
-100
Closed -$1K 5276
2013
Q2
$1K Buy
+100
New +$498 ﹤0.01% 4951

Other funds holding CPIX

Group One Trading's CPIX Position: Q4 2025 in Review

Group One Trading sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2025, closing a stake of 7,742 shares — an estimated $22.9K sold.

Group One Trading first reported a position in CPIX in Q2 2013 and held it in 4 quarters. The position peaked at $27.5K in Q2 2025. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2025.

  • Group One Trading reported no remaining Cumberland Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 7,742 Cumberland Pharmaceuticals shares in Q4 2025, an estimated $22.9K.
  • Group One Trading first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Group One Trading's Cumberland Pharmaceuticals position peaked at $27.5K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.